Hematology
1496 articles · 38 journals
Journals in this subcategory (38)
- Annals of Thoracic Surgery Short Reports · Elsevier (99)
- Blood Advances · Elsevier (99)
- Journal of Thrombosis and Haemostasis · Elsevier (95)
- Research and Practice in Thrombosis and Haemostasis · Elsevier (89)
- British Journal of Haematology · Wiley (80)
- Thrombosis Research · Elsevier (80)
- European Journal of Haematology · Wiley (79)
- Blood · Elsevier (75)
- Clinical Lymphoma, Myeloma & Leukemia · Elsevier (71)
- Vox Sanguinis · Wiley (70)
- Transfusion and Apheresis Science · Elsevier (69)
- Radiotherapy & Oncology · Elsevier (66)
- Annals of Oncology · Elsevier (64)
- Haemophilia · Wiley (63)
- American Journal of Hematology · Wiley (58)
- Transfusion · Wiley (54)
- Hematology/Oncology Clinics of North America · Elsevier (50)
- Transfusion Medicine Reviews · Elsevier (39)
- Seminars in Hematology · Elsevier (37)
- Seminars in Oncology · Elsevier (29)
- The Lancet Haematology · Elsevier (28)
- Experimental Hematology · Elsevier (22)
- Transfusion Medicine · Wiley (18)
- HemaSphere · Wiley (17)
- Thrombosis Update · Elsevier (15)
- Journal of Clinical Apheresis · Wiley (12)
- Blood Cancer Journal · Springer Nature (7)
- Leukemia · Springer Nature (7)
- Ca-A Cancer Journal for Clinicians · Wiley (4)
- Annals of Hematology · Springer Nature (0)
- Blood Research · Springer Nature (0)
- Experimental Hematology & Oncology · Springer Nature (0)
- Indian Journal of Hematology and Blood Transfusion · Springer Nature (0)
- International Journal of Clinical Oncology · Springer Nature (0)
- International Journal of Hematology · Springer Nature (0)
- Medical Oncology · Springer Nature (0)
- Thrombosis Journal · Springer Nature (0)
- memo - Magazine of European Medical Oncology · Springer Nature (0)
- Public perspectives on potential changes to malaria deferral criteria in Canada
- Evaluation of data from the hPSCreg®, a global registry for human pluripotent stem cell lines (hPSC‐lines)
- Prevalence, incidence and residual risk of HBV, HCV and HIV in Turkish Red Crescent blood donors: A 9‐year survey initiated with the implementation of nucleic acid testing (2015–2023)
- Beyond universal mitigation: Risk‐stratified approaches for preventing vasovagal reactions in blood donors
- Comment on ‘Comparing specificity and seroconversion sensitivity among major blood screening assays for human immunodeficiency virus and viral hepatitis’
- Response to ‘Beyond universal mitigation: Risk‐stratified approaches for preventing vasovagal reactions in blood donors’
- Response to: Comment on ‘Comparing specificity and seroconversion sensitivity among major blood screening assays for human immunodeficiency virus and viral hepatitis’
- Discordant prenatal and postnatal RhD typing caused by a novel RHD frameshift variant (c.540del; p.Leu181CysfsTer48) in Swedish individuals
- Voluntary non‐remunerated plasma collection in Denmark: Experiences from the Central Denmark Region
- Risk of vasovagal reactions among trans versus cisgender whole blood donors
- MicroRNA profiles as quality biomarkers in stored blood components: A narrative review
- Events
- Issue Information
- From war zones to blood deserts: Walking blood banks save lives
- Innovations in drone‐based blood delivery: Comparing implementation in Rwanda and Canada
- Hyperdiploid multiple myeloma: A heterogeneous entity requiring refined risk stratification—Insights from chromosome count and cytogenetic abnormalities
- A pro‐inflammatory cytokine signature characterises thrombotic antiphospholipid syndrome despite stable anticoagulation
- Comparison of venetoclax and azacitidine versus a cytarabine‐based treatment for patients with acute myeloid leukaemia in first relapse after chemotherapy. A real‐world study of the DATAML‐IPC‐AURAML consortium
- Evaluation of the UK Myeloma Research Alliance risk profile in transplant‐ineligible multiple myeloma patients treated with novel agents
- Survival after first relapse in marginal zone lymphomas: Prospective data from the international observational NF10 study
- Development and validation of a model for stratifying haematological malignancy risk in primary care using basic blood tests
- Role of direct‐acting antivirals in people with HIV‐associated non‐Hodgkin lymphoma and concomitant HCV infection: A study on behalf of the Fondazione Italiana Linfomi
- Warm autoimmune haemolytic anaemia in Taiwan: A population‐based study of epidemiology, treatment patterns, survival and healthcare utilisation (2017–2022)
- Cellular and molecular impacts of CELMoDs and IMiD on the induction of myeloid‐derived suppressor cells by myeloma cells
- Enhanced prognosis of acute myeloid leukaemia patients with dmCEBPAbZIP‐inf mutations: Insights from a multicentre Chinese cohort study
- SLIT2 modulates leukaemic cell proliferation and stromal support in acute myeloid leukaemia models
- SENIOR‐IPI: An easily applicable prognostic index for first‐line large B‐cell lymphomas patients >80 years treated with curative intent
- Use of selective serotonin reuptake inhibitors and risk of myeloid malignancy: A nationwide Danish case–control study
- Real‐world outcomes of ide‐cel and cilta‐cel in relapsed/refractory multiple myeloma: A nationwide, retrospective analysis in Austria
- Distinct clinical and genetic characteristics of myelodysplastic syndrome in younger patients